SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-011208
Filing Date
2022-08-12
Accepted
2022-08-12 16:46:26
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 721443
2 CERTIFICATION edsa_ex311.htm EX-31.1 9572
3 CERTIFICATION edsa_ex312.htm EX-31.2 9528
4 CERTIFICATION edsa_ex321.htm EX-32.1 3615
5 CERTIFICATION edsa_ex322.htm EX-32.2 3441
  Complete submission text file 0001654954-22-011208.txt   3523013

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20220630.xsd EX-101.SCH 43431
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20220630_lab.xml EX-101.LAB 226144
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20220630_cal.xml EX-101.CAL 39190
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20220630_pre.xml EX-101.PRE 186324
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20220630_def.xml EX-101.DEF 87306
53 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 544892
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 221160833
SIC: 2834 Pharmaceutical Preparations